Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Patients arriving at hospital emergency departments with acute ankle sprains can expect more timely advice and follow-up care in future after researchers in Oxford developed a new tool that will aid clinical decisions on treatment.

Hands holding a foot with the ankle coloured red to show a sprain

Ankle sprains are very common and represent up to 5% of all A&E admissions in the UK; between 20% and 30% of those patients are still struggling with pain and mobility issues nine months later.

The researchers at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) at the University of Oxford, supported by the NIHR Oxford Biomedical Research Centre and the NIHR's Health Technology Assessment programme, aimed to develop a prognostic model for identifying those people at a higher risk of poor outcome after an acute ankle sprain.

Their study on the SPRAINED (Synthesising a clinical Prognostic Rule for Ankle Injuries in the Emergency Department) prognostic model was published in the open access BMJ Open journal on Tuesday 6 November.

Dr David Keene of NDORMS, who was part of the team who led the study, said: "Many patients arrive at A&E in a lot of pain, making these injuries very difficult to assess. Currently, the majority of patients are not referred for follow-up visits to monitor progress or physiotherapy, as clinicians cannot predict who will recover and who would potentially benefit from further care.

"The new SPRAINED tool will provide clinicians with a risk score, supporting their decision-making process when providing advice to people with ankle sprains, and when deciding on ongoing management."

The tool was developed by a team of researchers, clinical practitioners and statisticians, based on data from a previous clinical trial on ankle sprains. SPRAINED was then tested on 682 patients at 10 emergency departments in the UK.

Whilst there are limitations, the research showed that the SPRAINED tool, which uses predictors that are simple to obtain during routine clinical assessment, gave a valuable insight on who could be at higher risk of a poor outcome, namely pain, lack of confidence and ongoing difficulties with the injured ankle.

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.

World Osteoporosis Day 2022

A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.